Advance in management of anti-MDA5 antibody-positive dermatomyositis: Conquering therapeutic obstacles
Int J Rheum Dis
.
2024 Nov;27(11):e15401.
doi: 10.1111/1756-185X.15401.
Authors
Po-Cheng Shih
1
2
,
Yung-Heng Lee
3
4
5
6
,
An-Ping Huo
2
7
,
Pui-Ying Leong
2
7
8
9
Affiliations
1
Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, Changhua Christian Hospital, Changhua, Taiwan.
2
Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
3
Department of Orthopedics, Cishan Hospital, Ministry of Health and Welfare, Kaohsiung, Taiwan.
4
Institute of Medical Science and Technology, National Sun Yat-sen University, Kaohsiung, Taiwan.
5
Department of Senior Services Industry Management, Minghsin University of Science and Technology, Hsinchu, Taiwan.
6
Department of Recreation and Sport Management, Shu-Te University, Kaohsiung, Taiwan.
7
Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan.
8
School of Medicine, Chung Shan Medical University, Taichung, Taiwan.
9
PhD Program of Business, Feng Chia University, Taichung, Taiwan.
PMID:
39498869
DOI:
10.1111/1756-185X.15401
No abstract available
Publication types
Editorial